Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-26 @ 2:41 AM
Study NCT ID:
NCT03298802
Status:
RECRUITING
Last Update Posted:
2023-12-05
First Post:
2017-09-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Sponsor:
The University of Texas Medical Branch, Galveston
Organization:
Study Overview
Official Title:
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide: a Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
Detailed Description:
To evaluate effectiveness of hydrochlorothiazide prophylaxis on prophylaxis, prevention and relapse of preeclampsia or gestational hypertension on readmission rates, need for additional antihypertensive therapy and number of triage visits.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: